| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T671 |
7-20 |
GO:0065007 |
denotes |
Dysregulation |
| T672 |
31-41 |
SP_7 |
denotes |
SARS-CoV-2 |
| T673 |
57-61 |
PR:000001393 |
denotes |
IL-6 |
| T674 |
95-100 |
UBERON:0001977 |
denotes |
serum |
| T675 |
112-116 |
PR:000001393 |
denotes |
IL-6 |
| T723 |
127-138 |
SP_7 |
denotes |
solute numb |
| T724 |
154-158 |
PR:000001393 |
denotes |
DR o |
| T676 |
160-164 |
PR:000001889 |
denotes |
CD14 |
| T677 |
165-174 |
CL:0000576 |
denotes |
monocytes |
| T725 |
192-197 |
UBERON:0001977 |
denotes |
rs) c |
| T726 |
209-213 |
PR:000001393 |
denotes |
of c |
| T727 |
256-260 |
PR:000001889 |
denotes |
rovi |
| T728 |
261-270 |
CL:0000576 |
denotes |
ed.
(B) C |
| T678 |
302-312 |
CL:0000542 |
denotes |
lymphocyte |
| T679 |
358-362 |
PR:000001889 |
denotes |
CD14 |
| T680 |
363-372 |
CL:0000576 |
denotes |
monocytes |
| T729 |
399-409 |
CL:0000542 |
denotes |
rrelation |
| T730 |
454-458 |
PR:000001889 |
denotes |
Chan |
| T731 |
459-468 |
CL:0000576 |
denotes |
es of the |
| T681 |
500-504 |
PR:000001889 |
denotes |
CD14 |
| T682 |
505-514 |
CL:0000576 |
denotes |
monocytes |
| T683 |
544-554 |
SP_7 |
denotes |
SARS-CoV-2 |
| T684 |
582-588 |
UBERON:0002405 |
denotes |
immune |
| T732 |
597-601 |
PR:000001889 |
denotes |
on a |
| T733 |
602-611 |
CL:0000576 |
denotes |
ter incub |
| T685 |
639-645 |
UBERON:0001969 |
denotes |
plasma |
| T734 |
641-651 |
SP_7 |
denotes |
asma.
(D) |
| T686 |
666-669 |
GO:0005675 |
denotes |
MFI |
| T687 |
673-676 |
PR:000029150 |
denotes |
HLA |
| T735 |
679-684 |
UBERON:0002405 |
denotes |
on C |
| T688 |
683-687 |
PR:000001889 |
denotes |
CD14 |
| T689 |
688-697 |
CL:0000576 |
denotes |
monocytes |
| T690 |
727-737 |
SP_7 |
denotes |
SARS-CoV-2 |
| T736 |
735-741 |
UBERON:0001969 |
denotes |
-2 wit |
| T737 |
762-765 |
GO:0005675 |
denotes |
of |
| T691 |
765-771 |
UBERON:0002405 |
denotes |
immune |
| T738 |
770-773 |
PR:000029150 |
denotes |
e a |
| T739 |
780-784 |
PR:000001889 |
denotes |
on a |
| T740 |
785-794 |
CL:0000576 |
denotes |
ter incub |
| T692 |
822-828 |
UBERON:0001969 |
denotes |
plasma |
| T741 |
824-834 |
SP_7 |
denotes |
asma.
(E) |
| T742 |
863-868 |
UBERON:0002405 |
denotes |
rs of |
| T693 |
880-884 |
PR:000001889 |
denotes |
CD14 |
| T694 |
885-894 |
CL:0000576 |
denotes |
monocytes |
| T743 |
919-925 |
UBERON:0001969 |
denotes |
ed by |
| T695 |
925-935 |
SP_7 |
denotes |
SARS-CoV-2 |
| T696 |
941-947 |
UBERON:0002405 |
denotes |
immune |
| T697 |
948-961 |
GO:0065007 |
denotes |
dysregulation |
| T744 |
977-981 |
PR:000001889 |
denotes |
n wi |
| T745 |
982-991 |
CL:0000576 |
denotes |
h medium |
| T698 |
1001-1007 |
UBERON:0001969 |
denotes |
plasma |
| T699 |
1009-1019 |
GO:0065007 |
denotes |
modulation |
| T746 |
1022-1032 |
SP_7 |
denotes |
the addit |
| T747 |
1038-1043 |
UBERON:0002405 |
denotes |
the |
| T748 |
1044-1057 |
GO:0065007 |
denotes |
pecific IL-6 |
| T700 |
1052-1056 |
PR:000001393 |
denotes |
IL-6 |
| T701 |
1065-1076 |
DG_35 |
denotes |
Tocilizumab |
| T749 |
1097-1103 |
UBERON:0001969 |
denotes |
hanges |
| T750 |
1105-1115 |
GO:0065007 |
denotes |
f the MFI |
| T702 |
1118-1121 |
PR:000029150 |
denotes |
HLA |
| T703 |
1128-1132 |
PR:000001889 |
denotes |
CD14 |
| T704 |
1133-1142 |
CL:0000576 |
denotes |
monocytes |
| T751 |
1148-1152 |
PR:000001393 |
denotes |
ght |
| T752 |
1161-1172 |
DG_35 |
denotes |
infected by |
| T705 |
1173-1183 |
SP_7 |
denotes |
SARS-CoV-2 |
| T706 |
1189-1195 |
UBERON:0002405 |
denotes |
immune |
| T707 |
1196-1209 |
GO:0065007 |
denotes |
dysregulation |
| T753 |
1215-1218 |
PR:000029150 |
denotes |
in |
| T754 |
1225-1229 |
PR:000001889 |
denotes |
n wi |
| T755 |
1230-1239 |
CL:0000576 |
denotes |
h medium |
| T708 |
1249-1255 |
UBERON:0001969 |
denotes |
plasma |
| T709 |
1257-1267 |
GO:0065007 |
denotes |
modulation |
| T756 |
1270-1280 |
SP_7 |
denotes |
the addit |
| T757 |
1286-1291 |
UBERON:0002405 |
denotes |
the |
| T758 |
1292-1305 |
GO:0065007 |
denotes |
pecific IL-6 |
| T710 |
1300-1304 |
PR:000001393 |
denotes |
IL-6 |
| T711 |
1313-1324 |
DG_35 |
denotes |
tocilizumab |
| T759 |
1345-1351 |
UBERON:0001969 |
denotes |
hanges |
| T760 |
1353-1363 |
GO:0065007 |
denotes |
f the abso |
| T712 |
1368-1378 |
CL:0000542 |
denotes |
lymphocyte |
| T761 |
1396-1400 |
PR:000001393 |
denotes |
ents |
| T762 |
1409-1420 |
DG_35 |
denotes |
nd after st |
| T713 |
1442-1453 |
DG_35 |
denotes |
Tocilizumab |
| T714 |
1459-1472 |
GO:0005622 |
denotes |
Intracellular |
| T763 |
1464-1474 |
CL:0000542 |
denotes |
cellular s |
| T715 |
1486-1490 |
PR:000001393 |
denotes |
IL-6 |
| T716 |
1494-1498 |
PR:000001889 |
denotes |
CD14 |
| T717 |
1499-1508 |
CL:0000576 |
denotes |
monocytes |
| T718 |
1516-1519 |
PR:000001004 |
denotes |
CD4 |
| T719 |
1520-1531 |
CL:0000542 |
denotes |
lymphocytes |
| T764 |
1538-1549 |
DG_35 |
denotes |
ee patients |
| T765 |
1555-1568 |
GO:0005622 |
denotes |
ted by SARS-C |
| T720 |
1562-1572 |
SP_7 |
denotes |
SARS-CoV-2 |
| T721 |
1578-1584 |
UBERON:0002405 |
denotes |
immune |
| T766 |
1583-1587 |
PR:000001393 |
denotes |
e dy |
| T722 |
1585-1598 |
GO:0065007 |
denotes |
dysregulation |
| T767 |
1591-1595 |
PR:000001889 |
denotes |
ulat |
| T768 |
1596-1605 |
CL:0000576 |
denotes |
on.
Stati |
| T769 |
1613-1616 |
PR:000001004 |
denotes |
omp |
| T770 |
1617-1628 |
CL:0000542 |
denotes |
risons are |
| T771 |
1659-1669 |
SP_7 |
denotes |
n-signific |
| T772 |
1675-1680 |
UBERON:0002405 |
denotes |
p < 0 |
| T773 |
1681-1694 |
GO:0065007 |
denotes |
05; ∗∗p < 0.0 |
